Alicia Purkey

896 total citations
18 papers, 599 citations indexed

About

Alicia Purkey is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Alicia Purkey has authored 18 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Alicia Purkey's work include Neuroscience and Neuropharmacology Research (5 papers), Cancer-related Molecular Pathways (4 papers) and Wnt/β-catenin signaling in development and cancer (3 papers). Alicia Purkey is often cited by papers focused on Neuroscience and Neuropharmacology Research (5 papers), Cancer-related Molecular Pathways (4 papers) and Wnt/β-catenin signaling in development and cancer (3 papers). Alicia Purkey collaborates with scholars based in United States, South Korea and Australia. Alicia Purkey's co-authors include Mark L. Dell’Acqua, Stacey M. Bagby, Wells A. Messersmith, John J. Arcaroli, Todd M. Pitts, Scott H. Soderling, Patricia F. Maness, Katherine T. Baldwin, Tetsuya Takano and Çağla Eroğlu and has published in prestigious journals such as Nature, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Alicia Purkey

18 papers receiving 593 citations

Peers

Countries citing papers authored by Alicia Purkey

Since Specialization

Citations

This map shows the geographic impact of Alicia Purkey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alicia Purkey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alicia Purkey more than expected).

Fields of papers citing papers by Alicia Purkey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alicia Purkey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alicia Purkey. The network helps show where Alicia Purkey may publish in the future.

Co-authorship network of co-authors of Alicia Purkey

This figure shows the co-authorship network connecting the top 25 collaborators of Alicia Purkey. A scholar is included among the top collaborators of Alicia Purkey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alicia Purkey. Alicia Purkey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	A Ventromedial Prefrontal-to-Lateral Entorhinal Cortex Pathway Modulates the Gain of Behavioral Responding During Threat 2023 ·Biological Psychiatry ·Erin Hisey, Alicia Purkey, Yudong Gao, (unknown), Scott H. Soderling, Kerry J. Ressler	4
2	Palmitoylation of A-kinase anchoring protein 79/150 modulates its nanoscale organization, trafficking, and mobility in postsynaptic spines 2022 ·Frontiers in Synaptic Neuroscience ·Xiaobing Chen, Kevin C. Crosby, Austin Y. Feng, Alicia Purkey, Maria A. Aronova, Christine A. Winters, (unknown), Richard D. Leapman, Thomas S. Reese, Mark L. Dell’Acqua	9
3	Chemico-genetic discovery of astrocytic control of inhibition in vivo 2020 ·Nature ·Tetsuya Takano, (unknown), Katherine T. Baldwin, Alicia Purkey, Akiyoshi Uezu, (unknown), Erik J. Soderblom, Tomomi Shimogori, Patricia F. Maness, Çağla Eroğlu, Scott H. Soderling	139
4	Phosphorylation-Dependent Regulation of Ca2+-Permeable AMPA Receptors During Hippocampal Synaptic Plasticity 2020 ·Frontiers in Synaptic Neuroscience ·Alicia Purkey, Mark L. Dell’Acqua	75
5	Local miRNA-Dependent Translational Control of GABAAR Synthesis during Inhibitory Long-Term Potentiation 2020 ·Cell Reports ·Dipen Rajgor, Alicia Purkey, Jennifer L. Sanderson, (unknown), (unknown), Mark L. Dell’Acqua, Katharine R. Smith	27
6	Antitumor activity of the polo-like kinase inhibitor, TAK-960, against preclinical models of colorectal cancer 2018 ·BMC Cancer ·(unknown), Stacey M. Bagby, Anna Capasso, Erica L. Bradshaw‐Pierce, Heather M. Selby, Anna Spreafico, John J. Tentler, Aik Choon Tan, Jihye Kim, John J. Arcaroli, Alicia Purkey, Wells A. Messersmith, Keisuke Kuida, Sabine Eckhardt, Todd M. Pitts	13
7	AKAP150 Palmitoylation Regulates Synaptic Incorporation of Ca2+-Permeable AMPA Receptors to Control LTP 2018 ·Cell Reports ·Alicia Purkey, Kevin M. Woolfrey, Kevin C. Crosby, Dominik Stich, Wallace S. Chick, Jason Aoto, Mark L. Dell’Acqua	57
8	Evaluation of the efficacy of dasatinib, a Src/Abl inhibitor, in colorectal cancer cell lines and explant mouse model 2017 ·PLoS ONE ·Aaron J. Scott, Eun‐Kee Song, Stacey M. Bagby, Alicia Purkey, Martin D. McCarter, Csaba Gajdos, Kevin S. Quackenbush, (unknown), Todd M. Pitts, Aik Choon Tan, Sabine Eckhardt, Hubert Fenton, John J. Arcaroli, Wells A. Messersmith	25
9	The novel tankyrase inhibitor (AZ1366) enhances irinotecan activity in tumors that exhibit elevated tankyrase and irinotecan resistance 2016 ·Oncotarget ·Kevin S. Quackenbush, Stacey M. Bagby, Wai Meng David Tai, Wells A. Messersmith, (unknown), Justin Greene, Jihye Kim, Guoliang Wang, Alicia Purkey, Todd M. Pitts, Anna Nguyen, Dexiang Gao, Patrick J. Blatchford, Anna Capasso, Alwin G. Schuller, S. Gail Eckhardt, John J. Arcaroli	31
10	Antitumor activity of the aurora a selective kinase inhibitor, alisertib, against preclinical models of colorectal cancer 2016 ·Oncotarget ·Todd M. Pitts, Erica L. Bradshaw‐Pierce, Stacey M. Bagby, (unknown), Heather M. Selby, Anna Spreafico, John J. Tentler, (unknown), (unknown), Anna Capasso, Jennifer R. Diamond, S. Lindsey Davis, Aik Choon Tan, John J. Arcaroli, Alicia Purkey, Wells A. Messersmith, (unknown), Sabine Eckhardt	25
11	A-kinase Anchoring Protein 79/150 Recruits Protein Kinase C to Phosphorylate Roundabout Receptors 2015 ·Journal of Biological Chemistry ·(unknown), Bryan B. Gore, (unknown), Patrick J. Nygren, Alicia Purkey, Marcie Colledge, Lorene K. Langeberg, Mark L. Dell’Acqua, Larry S. Zweifel, John D. Scott	13
12	Aldehyde Dehydrogenase 1B1 as a Modulator of Pancreatic Adenocarcinoma 2015 ·Pancreas ·Surendra Singh, John J. Arcaroli, David J. Orlicky, Ying Chen, Wells A. Messersmith, Stacey M. Bagby, Alicia Purkey, Kevin S. Quackenbush, David C. Thompson, Vasilis Vasiliou	23
13	Dual Pharmacological Targeting of the MAP Kinase and PI3K/mTOR Pathway in Preclinical Models of Colorectal Cancer 2014 ·PLoS ONE ·Todd M. Pitts, (unknown), Erica L. Bradshaw‐Pierce, (unknown), John J. Arcaroli, (unknown), Stacey M. Bagby, (unknown), Alicia Purkey, John J. Tentler, Aik Choon Tan, Wells A. Messersmith, Sabine Eckhardt, Stephen Leong	44
14	Potent antitumor activity of cabozantinib, a c‐MET and VEGFR2 inhibitor, in a colorectal cancer patient‐derived tumor explant model 2014 ·International Journal of Cancer ·Eun‐Kee Song, (unknown), Wells A. Messersmith, Stacey M. Bagby, Alicia Purkey, Kevin S. Quackenbush, Todd M. Pitts, Guoliang Wang, Patrick J. Blatchford, (unknown), Jeffrey Kaplan, Aik Choon Tan, Chloé E. Atreya, Gail Eckhardt, Robin Kate Kelley, Alan P. Venook, Eunice L. Kwak, David P. Ryan, John J. Arcaroli	49
15	Estimating the Sex-Specific Effects of Genes on Facial Attractiveness and Sexual Dimorphism 2013 ·Behavior Genetics ·(unknown), Alicia Purkey, Nicholas M. Grebe, Gregory Carey, Christine E. Garver‐Apgar, Timothy C. Bates, Rosalind Arden, John K. Hewitt, Sarah E. Medland, Nicholas G. Martin, Brendan P. Zietsch, Matthew C. Keller	23
16	Tumours with elevated levels of the Notch and Wnt pathways exhibit efficacy to PF-03084014, a γ-secretase inhibitor, in a preclinical colorectal explant model 2013 ·British Journal of Cancer ·John J. Arcaroli, Kevin S. Quackenbush, Alicia Purkey, (unknown), Todd M. Pitts, Stacey M. Bagby, Aik Choon Tan, (unknown), (unknown), (unknown), Wai Meng David Tai, Robert A. Winn, (unknown), (unknown), Sabine Eckhardt, Wells A. Messersmith	34
17	Abstract B30: KRAS wild type tumors exhibit increased efficacy to the combination of AZ1 (a tankyrase inhibitor) + irinotecan in a patient-derived CRC explant model. 2013 ·Molecular Cancer Therapeutics ·(unknown), Kevin S. Quackenbush, Alicia Purkey, Stacey M. Bagby, Wells A. Messersmith, (unknown), Todd M. Pitts, John J. Arcaroli	1
18	Abstract LB-302: Potent antitumor activity of XL184 (cabozantinib), a c-MET and VEGFR2 inhibitor, in colorectal cancer patient-derived tumor explant models. 2013 ·Cancer Research ·Chloé E. Atreya, Eun‐Kee Song, Wells A. Messersmith, Alicia Purkey, Stacey M. Bagby, Kevin S. Quackenbush, Robin Kate Kelley, Eunice L. Kwak, David P. Ryan, Alan P. Venook, John J. Arcaroli	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact